Having identified MYCN as a potential direct suppressor of the expression of ADAM17 and γ-secretase complex encoding genes, we sought to test whether MYCN genetic or pharmacological depletion in NB would increase their expression. The gene discussed is MYCN; the disease is neuroblastoma.